Test Price
320 AED✅ Home Collection Available
Estradiol Ultrasensitive Test in Dubai | 320 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189:2022 Accredited Processing at DNA Labs UAE.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by a DHA-licensed General Practitioner.
- Insurance: Direct Billing & Coverage Verification via WhatsApp +971 54 548 8731.
* For patients under 18 years, valid guardian consent is required per UAE Federal Law. All personal and medical data is protected under UAE PDPL. Laboratory services comply with DHA standards and hold ISO 9001:2015 Certification (INT/EGQ/2509DA/3139).
Test Overview & Methodology
The Estradiol Ultrasensitive Test provides the most accurate measurement of 17-beta-estradiol, the principal female sex hormone, employing Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) to reach picogram-level sensitivity. This technique eliminates cross-reactivity seen in older immunoassays, rendering it essential for evaluating menopause, pediatric endocrinology, male hypogonadism, sports endocrinology, and anti-aging therapies.
The test requires 2 mL serum from a plain red-top tube (no additive); SST gel barrier tubes are strictly prohibited. Specimens are shipped under refrigerated conditions to maintain stability. Results are reported within 2–3 working days depending on collection day and laboratory workflow.
| Parameter | Our LC-MS/MS Test | Standard Immunoassay (EIA) |
|---|---|---|
| Technology | LC-MS/MS (Tandem Mass Spectrometry) | Enzyme Immunoassay |
| Sensitivity | Picogram/mL – detects trace levels | Nanogram/mL – unreliable at low ends |
| Turnaround Time | 2–3 Working Days | 3–5 Business Days |
| Clinical Relevance | Gold‑standard for menopause, pediatric, anti‑aging & sports endocrinology | Adequate only for routine screening |
Physician Insight & Safety Protocols
"An ultrasensitive estradiol level must never be interpreted in isolation. The result must always be correlated with the patient's menstrual phase, age, clinical symptoms, and medication history. An abnormally high or low value can indicate conditions ranging from ovarian insufficiency to estrogen-producing tumors, but it requires a comprehensive clinical workup for confirmation. Never discontinue or alter prescribed hormone therapy based solely on a single test result without explicit guidance from your treating physician."
— Dr. Ajay Singh, General Practitioner, DHA License 36234132
Medical Advisory & Contraindications
⚠️ Important Safety Information
- This test is not appropriate within 48 hours of receiving radioiodine contrast or certain hormone interventions; acute febrile illness may also transiently alter results. Please inform our clinical team of any acute condition or recent contrast studies.
- ER Red Flags: If you experience severe lower abdominal pain, heavy abnormal vaginal bleeding, sudden vision loss, or signs of deep vein thrombosis (leg swelling/pain) after starting or adjusting estrogen therapy, seek immediate medical attention.
Exclusion Criteria & Emergency Indicators
Contraindications & When to Seek Emergency Care
- Contraindications: Patients who have received radioiodine contrast within the last 48 hours or those currently experiencing acute febrile illness should reschedule their sample collection.
- Emergency Symptoms: Severe lower abdominal pain, heavy abnormal vaginal bleeding, sudden vision loss, or signs of deep vein thrombosis (leg swelling/pain) after starting/adjusting estrogen therapy warrant immediate emergency medical intervention.
Patient FAQ & Clinical Guidance
1. What exactly does an ultrasensitive estradiol test measure, and why is the ultrasensitive method important?
This test precisely quantifies estradiol, the primary female sex hormone, in blood using mass spectrometry with detection limits down to picogram levels. The ultra‑high sensitivity is critical for accurately measuring low estrogen concentrations in men, postmenopausal women, and children, where standard assays fail. Elevated or suppressed values guide fertility treatments, hormone replacement monitoring, and evaluate gonadal function.
2. How should I prepare for the blood draw, and are there any restrictions?
No fasting or special preparation is needed; simply inform our phlebotomist to use a red-top tube without gel barrier. For healthcare providers: do not use SST gel separator tubes, as they introduce interference. The sample must be transported under refrigeration to guarantee stability. Our VIP mobile phlebotomy team adheres to strict cold‑chain protocols.
3. When will I receive my results, and how are they clinically interpreted?
Results are typically available within 2–3 working days. A telephonic post-test consultation with a DHA-licensed General Practitioner will explain the values in clinical context. The report includes age‑ and sex‑specific reference ranges, along with a brief interpretive comment by the laboratory. In the UAE, interpretation must be correlated with symptoms and imaging by a DHA‑licensed physician.
UAE Regulatory & Data Privacy Adherence
Your Data, Your Confidence
- Data Protection: DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All personal and medical data is encrypted and processed within secure UAE-based servers.
- Medical Liability: Clinical testing, patient consent, and safety protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring full legal protection for patients and ethical medical practice.
- Accreditation: The laboratory holds ISO 9001:2015 Certification (INT/EGQ/2509DA/3139) and operates under DHA Facility License Number 1143.
Clinical & Logistical Metadata
| Test Name | Estradiol Ultrasensitive (LC-MS/MS) |
| Price (AED) | 320 AED |
| Turnaround Time | 2 – 3 Working Days |
| Sample Type / Matrix | Serum (Red-top tube, no gel barrier) |
| Methodology Used | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) |
| ICD-10-CM Code | E28.3, N95.0, Z01.4 |
| LOINC Code | 2114-0 |
| DHA Facility License & Laboratory Address Invariants | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians